Against this backdrop, BCA Research recommended investors take an “overweight” position in U.S. equities relative to global stocks, namely those from China and Europe, “until China launches a ...

The U.S. infrastructure construction landscape continues to benefit from sustained public and private investment as demand ...

Union Pacific stock is rated a Buy, with strong earnings, dividend growth, and the potential for double-digit annual returns.

On December 12, India's stock market extended gains, buoyed by global sentiment after a US rate cut. Analysts forecast steady ...

Discover why SCHD is a top choice for long-term investors, offering strong dividend growth, smart portfolio strategy, and ...

This year brought a lot of twists and turns for investors. It began on an optimistic note as the new President, Donald Trump, ...

As you can see, Alphabet's 64% return trounced the rest of the Magnificent Seven, beating 2025's second-best performer, ...

The shares of the newly-listed company dropped to Rs 121.40, the lowest level seen by the stock since its market debut in September.

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Nifty futures on the NSE International Exchange traded 90.40 points, or 0.35 per cent, down at 26,055, hinting at a positive ...

Indian markets are likely to open lower tracking global weakness in technology stocks, though rotation into large caps and ...

Detailed price information for Stillwater Critical Minerals (PGE-X) from The Globe and Mail including charting and trades.